{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:08:36Z","timestamp":1757700516480,"version":"3.37.3"},"reference-count":29,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T00:00:00Z","timestamp":1495065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"sanofiaventis"},{"name":"Bristol-Myers Squibb"},{"name":"Waksman Foundation"},{"name":"World Heart Federation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Cardiology"],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The benefit of aspirin among patients with stable atherosclerosis without a prior ischemic event is not well defined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Hypothesis<\/jats:title><jats:p>Aspirin would be of benefit in outpatients with atherosclerosis with prior ischemic events, but not in those without ischemic events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Subjects from the Reduction of Atherothrombosis for Continued Health registry were divided according to prior ischemic event (n =21\u2009724) vs stable atherosclerosis, but no prior ischemic event (n\u2009=\u200911\u2009872). Analyses were propensity score matched. Aspirin use was updated at each clinic visit and considered as a time\u2010varying covariate. The primary outcome was the first occurrence of cardiovascular death, myocardial infarction, or stroke.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the group with a prior ischemic event, aspirin use was associated with a marginally lower risk of the primary outcome at a median of 41 months (hazard ratio [<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>]: 0.81, 95% confidence interval [<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>]: 0.65\u20101.01, <jats:italic>P<\/jats:italic> = 0.06). In the group without a prior ischemic event, aspirin use was not associated with a lower risk of the primary outcome at a median of 36 months (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>: 1.03, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0.73\u20101.45, <jats:italic>P<\/jats:italic> = 0.86).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this observational analysis of outpatients with stable atherosclerosis, aspirin was marginally beneficial among patients with a prior ischemic event; however, there was no apparent benefit among those with no prior ischemic event.<\/jats:p><\/jats:sec>","DOI":"10.1002\/clc.22724","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T16:45:10Z","timestamp":1495125910000},"page":"732-739","source":"Crossref","is-referenced-by-count":8,"title":["Aspirin and the risk of cardiovascular events in atherosclerosis patients with and without prior ischemic events"],"prefix":"10.1002","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3545-370X","authenticated-orcid":false,"given":"Anthony A.","family":"Bavry","sequence":"first","affiliation":[{"name":"Department of Medicine University of Florida  Gainesville Florida"},{"name":"North Florida\/South Georgia Veterans Health System  Gainesville Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9853-7591","authenticated-orcid":false,"given":"Islam Y.","family":"Elgendy","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Florida  Gainesville Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yedid","family":"Elbez","sequence":"additional","affiliation":[{"name":"D\u00e9partement Hospitalo\u2010Universitaire FIRE Universit\u00e9 Paris Diderot, AP\u2010HP, H\u00f4pital Bichat, and INSERM U\u20101148  Paris France"},{"name":"FACT (French Alliance for Cardiovascular Clinical Trials) H\u00f4pital Bichat, Assistance Publique\u2010H\u00f4pitaux de Paris  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed N.","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Florida  Gainesville Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0559-6301","authenticated-orcid":false,"given":"Emmanuel","family":"Sorbets","sequence":"additional","affiliation":[{"name":"D\u00e9partement Hospitalo\u2010Universitaire FIRE Universit\u00e9 Paris Diderot, AP\u2010HP, H\u00f4pital Bichat, and INSERM U\u20101148  Paris France"},{"name":"FACT (French Alliance for Cardiovascular Clinical Trials) H\u00f4pital Bichat, Assistance Publique\u2010H\u00f4pitaux de Paris  Paris France"},{"name":"Service de cardiologie H\u00f4pital Avicenne, AP\u2010HP, and Universit\u00e9 Paris 13  Bobigny France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe Gabriel","family":"Steg","sequence":"additional","affiliation":[{"name":"D\u00e9partement Hospitalo\u2010Universitaire FIRE Universit\u00e9 Paris Diderot, AP\u2010HP, H\u00f4pital Bichat, and INSERM U\u20101148  Paris France"},{"name":"FACT (French Alliance for Cardiovascular Clinical Trials) H\u00f4pital Bichat, Assistance Publique\u2010H\u00f4pitaux de Paris  Paris France"},{"name":"National Heart and Lung Institute Royal Brompton Hospital  Imperial College London United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-6245","authenticated-orcid":false,"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital Heart and Vascular Center Harvard Medical School  Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the REACH Registry Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,5,18]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"349","article-title":"ISIS\u20102 (Second International Study of Infarct Survival) Collaborative Group","volume":"2","author":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS\u20102","year":"1988","journal-title":"Lancet"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)04011-7"},{"key":"e_1_2_6_4_1","first-page":"81","article-title":"Antiplatelet Trialists' Collaboration","volume":"308","author":"Collaborative overview of randomised trials of antiplatelet therapy\u2014I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","year":"1994","journal-title":"BMJ"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht296"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.80a.12146"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e318235eb4d"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.09.028"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1322"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.2.180"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.11.004"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.11.1197"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22562"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/00273171.2011.568786"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1020363010465"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-016-0135-1"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj047"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00250-8"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30468-8"},{"key":"e_1_2_6_21_1","first-page":"625","article-title":"The Coronary Drug Project Research Group","volume":"29","author":"Aspirin in coronary heart disease","year":"1976","journal-title":"J Chronic Dis"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jama.1980.03300330019023","article-title":"A randomized, controlled trial of aspirin in persons recovered from myocardial infarction","volume":"243","author":"Aspirin Myocardial Infarction Study Group","year":"1980","journal-title":"JAMA"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.021177"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61720-0"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2007.10.002"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92619-Q"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-10-835"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.12559"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.2174\/1574890109666140901144210"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61088-4"}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.22724","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/clc.22724","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/clc.22724","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/clc.22724","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T09:32:20Z","timestamp":1694683940000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.22724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,18]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.1002\/clc.22724"],"URL":"https:\/\/doi.org\/10.1002\/clc.22724","archive":["Portico"],"relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"type":"print","value":"0160-9289"},{"type":"electronic","value":"1932-8737"}],"subject":[],"published":{"date-parts":[[2017,5,18]]}}}